BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 27496347)

  • 1. Basement membranes and autoimmune diseases.
    Foster MH
    Matrix Biol; 2017 Jan; 57-58():149-168. PubMed ID: 27496347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing B cell tolerance to basement membranes.
    Foster MH; Zhang Y; Clark AG
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):227-37. PubMed ID: 16830221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear anti-glomerular basement membrane IgG but no glomerular disease: Goodpasture's syndrome restricted to the lung.
    Sethi S; Lewin M; Lopez L; Lager D
    Nephrol Dial Transplant; 2007 Apr; 22(4):1233-5. PubMed ID: 17277338
    [No Abstract]   [Full Text] [Related]  

  • 5. A murine Ig light chain transgene reveals IGKV3 gene contributions to anti-collagen types IV and II specificities.
    Clark AG; Worni-Schudel IM; Korte FM; Foster MH
    Mol Immunol; 2017 Nov; 91():49-56. PubMed ID: 28886586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
    Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
    J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism.
    Wu J; Hicks J; Ou C; Singleton D; Borillo J; Lou YH
    J Immunol; 2001 Aug; 167(4):2388-95. PubMed ID: 11490029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on antiglomerular basement membrane disease.
    Peto P; Salama AD
    Curr Opin Rheumatol; 2011 Jan; 23(1):32-7. PubMed ID: 21124085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease.
    Shen CR; Jia XY; Luo W; Olaru F; Cui Z; Zhao MH; Borza DB
    J Am Soc Nephrol; 2021 Aug; 32(8):1887-1897. PubMed ID: 33893224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goodpasture's syndrome: a report of an autopsy case and a review of Japanese cases.
    Wakui H; Chubachi A; Asakura K; Nishimura S; Nakamoto Y; Miura AB
    Intern Med; 1992 Jan; 31(1):102-7. PubMed ID: 1568028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture syndrome: molecular architecture and function of basement membrane antigen.
    Hudson BG; Wieslander J; Wisdom BJ; Noelken ME
    Lab Invest; 1989 Sep; 61(3):256-69. PubMed ID: 2671489
    [No Abstract]   [Full Text] [Related]  

  • 13. Goodpasture syndrome.
    Kalluri R
    Kidney Int; 1999 Mar; 55(3):1120-2. PubMed ID: 10027952
    [No Abstract]   [Full Text] [Related]  

  • 14. Goodpasture's disease and Alport's syndromes.
    Turner AN; Rees AJ
    Annu Rev Med; 1996; 47():377-86. PubMed ID: 8712789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goodpasture's disease: Antiglomerular basement membrane disease.
    Erlich JH; Sevastos J; Pussell BA
    Nephrology (Carlton); 2004 Apr; 9(2):49-51. PubMed ID: 15056260
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
    Kalluri R; Danoff TM; Okada H; Neilson EG
    J Clin Invest; 1997 Nov; 100(9):2263-75. PubMed ID: 9410904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity and glomerulonephritis.
    Lockwood CM; Bowman C; Bakes D; Pressey A; Dash A
    Adv Nephrol Necker Hosp; 1987; 16():291-306. PubMed ID: 3101428
    [No Abstract]   [Full Text] [Related]  

  • 18. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell epitope mimicry in antiglomerular basement membrane disease.
    Arends J; Wu J; Borillo J; Troung L; Zhou C; Vigneswaran N; Lou YH
    J Immunol; 2006 Jan; 176(2):1252-8. PubMed ID: 16394016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
    Ooi JD; Holdsworth SR; Kitching AR
    J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.